This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1977 Jan 8;1(6053):96-7.

doi: 10.1136/bmj.1.6053.96.

Monitoring adverse reactions to drugs

C T Dollery, M D Rawlins

PMID: 832028
PMCID: PMC1604057
DOI: 10.1136/bmj.1.6053.96

Monitoring adverse reactions to drugs

C T Dollery et al. Br Med J. 1977.

. 1977 Jan 8;1(6053):96-7.

doi: 10.1136/bmj.1.6053.96.

Authors

C T Dollery, M D Rawlins

PMID: 832028
PMCID: PMC1604057
DOI: 10.1136/bmj.1.6053.96

No abstract available

PubMed Disclaimer

Similar articles

New strategies for drug monitoring.
[No authors listed] [No authors listed] Br Med J. 1977 Apr 2;1(6065):861-2. Br Med J. 1977. PMID: 851762 Free PMC article. No abstract available.
Post-marketing surveillance of adverse reactions to new medicines.
Wilson AB. Wilson AB. Br Med J. 1977 Oct 15;2(6093):1001-3. doi: 10.1136/bmj.2.6093.1001. Br Med J. 1977. PMID: 922357 Free PMC article. No abstract available.
A prescription for monitoring drugs.
Marshall E. Marshall E. Science. 1980 Feb 22;207(4433):853-5. doi: 10.1126/science.7355265. Science. 1980. PMID: 7355265 No abstract available.
Methods of monitoring adverse reactions to drugs.
Venulet J. Venulet J. Prog Drug Res. 1977;21:231-92. doi: 10.1007/978-3-0348-7098-6_3. Prog Drug Res. 1977. PMID: 339270 Review. No abstract available.
Improving how we evaluate the toxicity of approved drugs.
Reidenberg MM. Reidenberg MM. Clin Pharmacol Ther. 2006 Jul;80(1):1-6. doi: 10.1016/j.clpt.2006.03.006. Epub 2006 Jun 8. Clin Pharmacol Ther. 2006. PMID: 16815311 Review. No abstract available.

See all similar articles

Cited by

Clinical pharmacology. Drug monitoring.
Moir DC. Moir DC. Br Med J (Clin Res Ed). 1981 Feb 21;282(6264):632-4. doi: 10.1136/bmj.282.6264.632. Br Med J (Clin Res Ed). 1981. PMID: 6781602 Free PMC article. No abstract available.
Post-marketing surveillance in the UK (1984).
Lawson DH. Lawson DH. Br J Clin Pharmacol. 1986;22 Suppl 1(Suppl 1):71S-75S. doi: 10.1111/j.1365-2125.1986.tb02986.x. Br J Clin Pharmacol. 1986. PMID: 3567035 Free PMC article. No abstract available.
Once is not enough.
Gross F. Gross F. Eur J Clin Pharmacol. 1977;11(5):323-4. doi: 10.1007/BF00566527. Eur J Clin Pharmacol. 1977. PMID: 880970 No abstract available.
Post marketing drug surveillance, another string to the bow.
Fell PJ, Watson NP, O'Donnell HF. Fell PJ, et al. Eur J Clin Pharmacol. 1978 Jun 19;13(4):315-6. doi: 10.1007/BF00716369. Eur J Clin Pharmacol. 1978. PMID: 668791 No abstract available.
Postmarketing surveillance of adverse drug reactions in general practice. I: search for new methods.
Inman WH. Inman WH. Br Med J (Clin Res Ed). 1981 Apr 4;282(6270):1131-2. doi: 10.1136/bmj.282.6270.1131. Br Med J (Clin Res Ed). 1981. PMID: 6786470 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central